Observational Comparison of Tooth-borne, Bone-borne and Hybrid Distraction Following SARPE.

Sponsor
ZOL (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04670211
Collaborator
(none)
90
32

Study Details

Study Description

Brief Summary

The investigators will perform a prospective, non-randomized observational study. The aim of this study is to evaluate stability of tooth-borne, bone-borne and hybrid expansion following SARPE by using data collected according to the existing SARPE follow-up protocol. The insights of this study might elucidate the preferred expansion technique and improve surgical technique.

Condition or Disease Intervention/Treatment Phase
  • Device: maxillary distractor

Detailed Description

Maxillary transverse discrepancy (MTD) is a difficult deformity to correct. In skeletal immature patients, an orthopedic-orthodontic expansion is the preferred treatment strategy. In case of a skeletal mature patient, a surgical treatment should be considered. A Surgically assisted Rapid Palatal Expansion (SARPE) procedure is a common surgical treatment for MTD in skeletal mature patients. In this procedure the skeletally mature, maxillary sutures are surgically reopened. One week postoperatively, the patient will activate the expander appliance. There are three widely-used expander appliances: tooth-borne, bone-borne and hybrid expanders. The use of the expander appliance is based on surgeon and referring orthodontist's common practice and preference. A tooth-borne expander is an appliance which is supported by the teeth and bridges the palate. A bone-borne expander is surgically placed at the level of the palate during SARPE surgery. Hybrid expansion is a combination of tooth-borne and bone-borne expansion. These appliances progressively widen the maxilla by daily activation of the distractor. The activation is stopped when the surgeon and/or referring orthodontist judge that the maxilla is sufficiently expanded. However, historical research with the use of cast model's and 2D posteroanterior cephalograms suggest that this expansion is not stable. With the emergence of 3D Cone-Beam Computed Tomography (CBCT) and its appliance as standard of care for pre-operative diagnosis and postoperative follow-up, stability and complications can be assessed more accurately. The goal of this study is to prospectively evaluate stability following SARPE, by analyzing the clinical and radiological data collected according to the existing clinical SARPE follow-up protocol. The secondary outcome is to evaluate complications following the three distractors.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
90 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Observational Comparison of Tooth-borne, Bone-borne and Hybrid Distraction Following SARPE.
Anticipated Study Start Date :
May 1, 2021
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Tooth-borne distractor

Maxillary distraction with the use of a tooth-borne distractor following Surgically-assisted Rapid Palatal Expansion (SARPE) surgery.

Device: maxillary distractor
the type of maxillary distractor: tooth-borne, bone-borne or hybrid distractor

Bone-borne distractor

Maxillary distraction with the use of a bone-borne distractor following Surgically-assisted Rapid Palatal Expansion (SARPE) surgery.

Device: maxillary distractor
the type of maxillary distractor: tooth-borne, bone-borne or hybrid distractor

Hybrid distractor

Maxillary distraction with the use of a hybrid distractor following Surgically-assisted Rapid Palatal Expansion (SARPE) surgery.

Device: maxillary distractor
the type of maxillary distractor: tooth-borne, bone-borne or hybrid distractor

Outcome Measures

Primary Outcome Measures

  1. Stability [1 year postoperatively]

    Stability of the maxillary expansion following SARPE. The stability will be evaluated by comparing the CBCT imaging which is taken at the time of maximal transversal maxillary expansion with the CBCT taken one year postoperatively. Width between the mesiobuccal cusps of the first molars and width between the cusps of the canines is measured. Moreover the width of the apertura piriformis and between the palatal foramen is examined in order to evaluate skeletal stability. This allows calculation of the dental and skeletal stability following SARPE.

Secondary Outcome Measures

  1. Complications [1 year postoperatively]

    Complications following SARPE surgery are examined. Anamnestic, clinical and radiographic information is examined in order to determine postoperative complications. The following complications can be examined: postoperative bleeding, mucosal infection, maxillary sinus infection, palatal necrosis, oro-antral communication, gingival recession, tooth discoloration, bone resorption, malunion, nonunion, root resorption, loss of teeth, mechanical failure of the distractor, asymmetric expansion, lacrimation.

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Maxillary transverse discrepancy

  • Skeletal mature patients

  • SARPE treatment is indicated

Exclusion Criteria:
  • Patients with a syndrome with an influence on head-and-neck morphology (such as Apert, Crouzon syndrome)

  • Cleft patients

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • ZOL

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Oliver da Costa Senior, dr. Oliver da Costa Senior (principle investigator), ZOL
ClinicalTrials.gov Identifier:
NCT04670211
Other Study ID Numbers:
  • CTU2020095
First Posted:
Dec 17, 2020
Last Update Posted:
Apr 20, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Oliver da Costa Senior, dr. Oliver da Costa Senior (principle investigator), ZOL
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 20, 2021